- Fast growing biomedical company backed up by top PE firms
- Executive team consists of top scientists and global pharmaceutical companies' e
About Our Client
Our client is a biomedical start up business founded by top scientists, aiming for IPO in HongKong. The company has a team of around 100 people based in north China. They have international executive team with scientific and commercial corporate experience. The product pipeline is very strong in their field at clinical stage 2/3 in oncology. The timeline for IPO will be in the next 12 to 15 months.
The CFO will lead the IPO process, heavily involved in business strategy and product portfolio planning as well as business development opportunities. He/she will work closely with the top management team as well as investors to drive funding and manage investor relations by presenting the business performance and reporting thoroughly. The CFO will manage the finance team and ensure sound risk/compliance processes are in place.
The Successful Applicant
The successful applicant is preferred to have investment banking experience, and has proven track record in leading IPO in HongKong. Alternatively, corporate finance candidate with capital market exposure is also considered. The CFO is required to have strong business acumen, sensitive to numbers with excellent problem solving and leadership skills.
What's on Offer
You will work closely with top scientists from the globe, they have years of research and clinical experience in the U.S. and China.
The CEO is U.S. returnee with working experience in a global pharmaceutical company.
Competitive cash plus stock option will be offered as your remuneration package